ArticleCancer medicine2026

Efficacy and Safety of Neoadjuvant Chemotherapy Followed by CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With HR-Positive, HER2-Negative Breast Cancer: A Retrospective Single-Centre Cohort Analysis.

Xiaopei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.